A Study to Evaluate the Potential Drug-Drug Interaction Between Danoprevir/Low-Dose Ritonavir When Given With Raltegravir in Healthy Adult Volunteers.
Phase of Trial: Phase I
Latest Information Update: 13 Jun 2016
At a glance
- Drugs Danoprevir (Primary) ; Raltegravir; Ritonavir
- Indications Hepatitis C; HIV infections; HIV-1 infections
- Focus Pharmacokinetics
- Sponsors Roche
- 20 Jan 2014 Actual end date changed from Aug 2012 to Mar 2012 as reported by ClinicalTrials.gov.
- 19 Sep 2012 Actual end date changed from May 2012 to Aug 2012 as reported by ClinicalTrials.gov.
- 01 May 2012 Actual end date (1 May 2012) added as reported by ClinicalTrials.gov.